Liver-specific agents for contrast-enhanced MRI: role in oncological imaging. - sprookjes - yvandenbroek - TriplyDB

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

http://www.wikidata.org/entity/Q37487034

about

Recent Advances in Tumor Ablation for Hepatocellular Carcinoma Focal liver lesions: Practical magnetic resonance imaging approach Silica nanoparticle-based dual imaging colloidal hybrids: cancer cell imaging and biodistribution Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions PET/MRI for the body imager: abdominal and pelvic oncologic applications.Defining Post Hepatectomy Liver Insufficiency: Where do We stand?An overview of imaging techniques for liver metastases management.Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command.

P2860

Q26775418-93B170F4-ECA6-43C2-B228-B4E04F574A21 Q26799474-A946054A-5B47-4959-BA1A-F48C316D2AF1 Q36024746-4B1C2729-D668-4E33-B7F9-E209D06B8367 Q36056202-332C4F8D-E4FF-4EEA-8E01-7D79EB516856 Q36570279-05FBA545-415D-4B4E-AD55-767A222BFA17 Q38389749-E7E72A6B-2691-4635-BC7B-72A62FEDA048 Q38524318-07CBD3B5-D8EC-47EB-916B-81D0EA43618E Q38594431-D13CB2A1-259B-490A-ADA6-C36489702843 Q42757759-0A76CCF2-8DA6-4B36-9F7E-915A2074DB41 Q51573720-A18C3702-B44F-4DC9-9F12-B1183242D633

P2860

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

http://www.wikidata.org/entity/Q37487034

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@en

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@nl

type

label

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@en

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@nl

prefLabel

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@en

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@nl

P1433

Q37487034-615CB3A7-0F6D-4811-81EF-B26ABFE33364

P1476

Q37487034-FAE6B3F7-9255-452C-A19C-64EEB5F0F580

P2093

Q37487034-E3E8F8DC-4248-4F75-8AA2-6F5F8874BA4E

P2860

Q37487034-011BCAC5-3857-40B9-A7A5-0823D91CE9D1

Q37487034-0400ACEE-F9E5-4685-8157-F4B1870FFCCA

Q37487034-088EF32F-3D4A-456B-B404-7F1A62FF7A5D

Q37487034-0B159550-A6D2-4613-9102-774C8C37164C

Q37487034-11DC61BF-C994-4AF6-9CBE-A6F35839FE4A

Q37487034-1283AF94-4E90-4D2F-A2CD-EE649D81AF2E

Q37487034-12861879-60CD-44E1-96A1-F31893E7DC3E

Q37487034-15154BC0-9431-4C93-B11E-EF7F7C5128C1

Q37487034-1677A3F2-7C7B-452E-B803-EA718E4A9310

Q37487034-1C543937-FADD-4540-983E-809DFD4A765A

P304

Q37487034-C38215A2-DEF1-46F6-8937-5D3F3D679D67

P31

Q37487034-658C4948-93E3-4F51-AF7E-426D5CB6BCD7

Q37487034-FAAC2AD8-5F48-4634-A200-043D62E16A15

P356

Q37487034-05EE1884-69C6-4B6B-B457-5D1B8BBD952E

P433

Q37487034-A02831E6-E038-4CA0-A9A0-ECDED379E8FB

P478

Q37487034-D275D673-256B-46D9-889A-C05B07BC0263

P50

Q37487034-4FF522E1-436F-4066-A433-A7B93C5CEFC4

Q37487034-E05C1AD8-88EA-41DD-8D11-F2C8BB889C23

P577

Q37487034-9E64CADB-445C-4063-B8E4-E0FEBBAB2BCB

P5875

Q37487034-5F5D7B7C-CAAB-40D2-82F2-BDB98A4F058D

P698

Q37487034-712F5A59-F768-4E96-A073-439DF5E482CC

P921

Q37487034-110E41CA-0E6E-4FED-BEA0-2DB39EDEEB8B

Q37487034-36594386-9831-4E21-939E-DE72A19A18D0

P932

Q37487034-60E2FF8E-2003-4AD1-9A41-8728116BFAF2

P356

1470-7330.2013.0050

P1433

P1476

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

@en

P2093

Angela M Riddell

http://www.w3.org/2001/XMLSchema#string

P2860

Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms

Primary liver cancer: worldwide incidence and trends

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.

Cholangiocarcinoma.

Unexpected uptake of gadoxetic acid in a hepatic metastasis from T-cell lymphoma.

Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases

Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid

Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.

P304

567-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1102/1470-7330.2013.0050

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Yee Liang Thian

P577

2013-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259770013

http://www.w3.org/2001/XMLSchema#string

P698

24434892

http://www.w3.org/2001/XMLSchema#string

P921

hepatocellular carcinoma

P932

3893895

http://www.w3.org/2001/XMLSchema#string